Table 2.
Clinical and background variables of each eGFR category
| eGFR Stage (n) |
5: GFR ≥ 90 (n = 127) |
4: GFR = 60–89 (n = 168) |
3: GFR = 30–59 (n = 76) |
2: GFR = 15–29(n = 10) | 1: GFR < 15 (n = 5) |
P value* |
|---|---|---|---|---|---|---|
| Age (years) | 53.1 ± 9.4 | 63.2 ± 8.9 | 67.2 ± 7.3 | 62.1 ± 9.8 | 65 ± 12.5 | < 0.001 |
| Systolic BP (mmHg) | 133 ± 16.5 | 139.3 ± 17.7 | 139.2 ± 19.9 | 153 ± 15.6 | 154 ± 22 | < 0.001 |
| Diastolic BP (mmHg) | 77.7 ± 11.4 | 76.5 ± 11.2 | 77.5 ± 10.5 | 80.1 ± 14 | 81.4 ± 6.8 | 0.883 |
| Hypertension Duration (years) | 6.5 ± 5 | 9.0 ± 7.4 | 11.0 ± 9 | 11.6 ± 13.3 | 12.6 ± 6.8 | 0.013 |
| HbA1c (%) | 8.58 ± 2 | 8.38 ± 1.98 | 8.57 ± 2.2 | 7.3 ± 1.7 | 6.4 ± 1.14 | 0.057 |
| Diabetes Duration (years) | 9.3 ± 6.6 | 12.9 ± 8.4 | 14.9 ± 8.8 | 16.8 ± 13.2 | 21.4 ± 9.8 | 0.007 |
*Kruskal Wallis test, BP Blood Pressure, eGFR Estimated glomerular filtration rate